Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018157769) METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONAL CELLS
Latest bibliographic data on file with the International Bureau    Submit observation
Pub. No.: WO/2018/157769 International Application No.: PCT/CN2018/077192
Publication Date: 07.09.2018 International Filing Date: 26.02.2018
IPC:
C12N 5/0793 (2010.01) ,A61K 45/00 (2006.01) ,A61K 31/4745 (2006.01) ,A61P 35/00 (2006.01) ,A61P 25/00 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07
Animal cells or tissues
071
Vertebrate cells or tissues, e.g. human cells or tissues
079
Neural cells
0793
Neurons
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
4738
ortho- or peri-condensed with heterocyclic ring systems
4745
condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
Applicants:
中国科学院动物研究所 INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES [CN/CN]; 中国北京市 朝阳区北辰西路1号院5号 No.5, 1 Beichen West Road, Chaoyang District Beijing 100101, CN
Inventors:
周琪 ZHOU, Qi; CN
李伟 LI, Wei; CN
胡宝洋 HU, Baoyang; CN
何正泉 HE, Zhengquan; CN
王柳 WANG, Liu; CN
郝捷 HAO, Jie; CN
Agent:
北京彩和律师事务所 BEIJING CAI HE LAW FIRM; 中国北京市 海淀区大柳树路17号富海国际港1902室 Room 1902, FuHai International Port, No. 17, Daliushu Road, Haidian District Beijing 100081, CN
Priority Data:
201710117871.501.03.2017CN
Title (EN) METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONAL CELLS
(FR) PROCÉDÉ DE TRANSDIFFÉRENCIATION DE CELLULES NON NEURONALES EN CELLULES NEURONALES
(ZH) 一种将非神经元细胞转化为神经元细胞的方法
Abstract:
(EN) Provided is a method for transdifferentiating non-neuronal cells into neuronal cells, comprising subjecting an extracellular matrix-skeleton system of the non-neuronal cells to an interference treatment. The interference treatment is selected from: treatment with small-molecule inhibitors of cytoskeletal proteins, a knockdown treatment of the expression of specific genes of the extracellular matrix-skeleton system by using small interfering RNA (siRNA), and a low-adhesion treatment and the directed differentiation culture of the extracellular matrix. This transdifferentiation method can be used for tissue regeneration, repair and tumour therapy.
(FR) L'invention concerne un procédé de transdifférenciation de cellules non neuronales en cellules neuronales, comprenant la soumission d'un système de squelette matriciel extracellulaire des cellules non neuronales à un traitement d'interférence. Le traitement d'interférence est choisi parmi : un traitement avec des inhibiteurs à petites molécules de protéines cytosquelettiques, un traitement d'inactivation de l'expression de gènes spécifiques du système de squelette matriciel extracellulaire à l'aide de petits ARN interférents (ARNsi) et un traitement à faible adhérence et la culture de différenciation dirigée de la matrice extracellulaire. Ce procédé de transdifférenciation peut être utilisé pour la régénération et la réparation tissulaires et la thérapie tumorale.
(ZH) 提供了一种将非神经元细胞转分化为神经元细胞的方法，包括对非神经元细胞的胞外基质-骨架系统进行干扰处理，该干扰处理选自：采用细胞骨架蛋白小分子抑制剂进行处理，采用小干扰RNA(siRNA)对胞外基质-骨架系统的特定基因表达进行敲低处理，对胞外基质进行低粘附处理并定向分化培养。该转分化的方法可用于组织再生、修复和肿瘤治疗。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)